TrialAsian Pacific journal of cancer prevention : APJCP2021

Efficacy of Neoadjuvant Single or Dual Anti-HER-2 Therapy Combined with Chemotherapy in Patients with HER-2-Positive Breast Cancer: A Single-Center Retrospective Study.

Qian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.